Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RZLT stock hub

Rezolute, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

RZLTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
333.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
RZLT
In the news

Latest news · RZLT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.6P50 18.3P75 33.7
Trailing P/En/a
P25 15P50 23.3P75 38.5
ROE-74
P25 -106.6P50 -46.9P75 -3.1
ROIC-47.9
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All RZLT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001509261
Company name
Rezolute, Inc.
Country
United States
Country code
US
Cusip
76200L309
Employees
75
Employees Change
4%
Employees Change Percent
5.63
Enterprise value
$201.8M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
US76200L3096
Last refreshed
2026-05-10
Market cap
$333.4M
Market cap category
Small-Cap
Price
$3.21
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
RZLT
Website
https://www.rezolutebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-25.26%
FCF yield
-23.14%
P/B ratio
2.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-84.2M
Net Income Growth Years
0%
Profit Per Employee
$-1.1M
ROA
-44.09
Roa5y
-34.46
ROCE
-68.48
ROE
-74.02
Roe5y
-64.2
ROIC
-47.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr10y
-23.7%
Cagr1y
-11.09%
Cagr3y
11.75%
Cagr5y
-13.16%
EPS Growth Years
1
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$138.6M
Cash
$132.9M
Current Assets
$135.1M
Current Liabilities
$9.5M
Debt
$1.3M
Debt Equity
$0.01
Equity
$128M
Liabilities
$10.6M
Long Term Assets
$3.5M
Long Term Liabilities
$1.1M
Net Cash
$131.7M
Net Cash By Market Cap
$39.48
Net Cash Growth
27.34%
Net Debt Equity
$-1.03
Tangible Book Value
$128M
Tangible Book Value Per Share
$1.23
WACC
7.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
14.18
Net Working Capital
$-6.7M
Quick ratio
13.95
Working Capital
$125.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-53.03%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

41
MetricValue
10Y total return
-93.31%
1Y total return
-11.08%
200-day SMA
5.59
3Y total return
39.57%
50-day SMA
3.13
50-day SMA vs 200-day SMA
50under200
5Y total return
-50.62%
All Time High
750
All Time High Change
-99.57%
All Time High Date
2013-02-08
All Time Low
0.72
All Time Low Change
345.83%
All Time Low Date
2023-11-30
ATR
0.23
Beta
0.67
Beta1y
1.15
Beta2y
1.36
Ch YTD
36.02
High
3.23
High52
11.46
High52 Date
2025-11-10
High52ch
-71.98%
Low
3.08
Low52
1.07
Low52 Date
2025-12-11
Low52ch
200%
Ma50ch
2.46%
Premarket Change Percent
1.94
Premarket Price
$3.15
Premarket Volume
12,586
Price vs 200-day SMA
-42.55%
RSI
49.32
RSI Monthly
44.37
RSI Weekly
43.36
Sharpe ratio
1.13x
Sortino ratio
1.47
Total Return
-53.03%
Tr YTD
36.02
Tr1m
-2.73%
Tr1w
-2.73%
Tr3m
2.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
6
Analyst Count Top
3
Analyst Price Target Top
$5.33
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.16
Operating Income
$-88.4M
Price target
$9.67
Price Target Change
$201
Price Target Change Top
$66.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
71,054,720%
Float Percent
68.41%
Shares Insiders
0.72%
Shares Institutions
76.22%
Shares Out
103,872,123
Shares Qo Q
0.26%
Shares Yo Y
53.03%
Short Float
18.11%
Short Ratio
3.99
Short Shares
12.39

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
$-87.4M
Average Volume
1,382,059.55x
Bv Per Share
1.23
Ch10y
-93.31
Ch1m
-2.73
Ch1w
-2.73
Ch1y
-11.08
Ch3m
2.89
Ch3y
39.57
Ch5y
-50.62
Ch6m
-70.17
Change
3.88%
Change From Open
3.88
Close
3.09
Days Gap
0
Depreciation Amortization
30,000
Dollar Volume
2,280,685.7
Earnings Date
2026-05-13
Earnings Time
amc
EBIT
$-88.4M
EBITDA
$-88.4M
EPS
$-0.91
F Score
2
FCF
$-77.1M
FCF EV Yield
-38.23x
FCF Per Share
$-0.74
Financing CF
102,437,000
Fiscal Year End
June
Founded
2,010
Investing CF
-22,276,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Last Split Date
2020-10-13
Last Split Type
Reverse
Last10k Filing Date
2025-09-17
Ma150
5.04
Ma150ch
-36.3%
Ma20
3.3
Ma20ch
-2.67%
Net CF
3,012,000
Next Earnings Date
2026-05-22
Open
3.09
Optionable
Yes
Position In Range
89.66
Ppne
1,121,000
Pre Close
3.09
Price Date
2026-05-08
Ptbv Ratio
2.6
Relative Volume
0.51x
Share Based Comp
10,218,000
Tr6m
-70.17%
Us State
California
Volume
710,494
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does RZLT pay a dividend?

Capital-return profile for this ticker.

Performance

RZLT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-11.1%
S&P 500 1Y: n/a
3Y total return
+39.6%
S&P 500 3Y: n/a
5Y total return
-50.6%
S&P 500 5Y: n/a
10Y total return
-93.3%
S&P 500 10Y: n/a
Ownership

Who owns RZLT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+76.2%
Float: +68.4% of shares outstanding
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+18.1%
4.0 days to cover
Y/Y dilution
+53.0%
Negative means the company is buying back shares.
Technical

RZLT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.3
Neutral momentum band
Price vs 200-day MA
-42.5%
50/200-day relationship not available
Beta (5Y)
0.67
Less volatile than the market
Sharpe ratio
1.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About RZLT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RZLT stock rating?

Rezolute, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RZLT analysis?

The full report lives at /stocks/RZLT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RZLT?

The latest report frames RZLT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RZLT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.